Dehydrozingerone protects temozolomide-induced cognitive impairment in normal and C6 glioma rats besides enhancing its anticancer potential

Considering the cognitive impairment induced by temozolomide (TMZ) in glioblastoma survivors, the present study was aimed to evaluate the protective effect of dehydrozingerone (DHZ) against TMZ-induced cognitive impairment (chemobrain) and C6 cell line-induced glioma in male Wistar rats. In both che...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:3 Biotech
Main Authors: Pathak, Nandini, Cheruku, Sri Pragnya, Rao, Vanishree, Vibhavari, R. J. A., Sumalatha, Suhani, Gourishetti, Karthik, Rao, C. Mallikarjuna, Kumar, Nitesh
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7498526/
https://ncbi.nlm.nih.gov/pubmed/32995109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13205-020-02427-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados